Guilin Sanjin Pharmaceutical Co., Ltd.
SHZ: 002275.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Xun Zou
- Employees
- 2,615
- Headquarters
- Guilin, China
- IPO year
- 2009
- Market cap
- CN¥8.5B
- Website
- https://www.sanjin.com.cn
Loading 002275…
Loading profile data…Frequently asked questions about 002275
What does Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) do?
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. The company was founded in 19...
Where does 002275.SZ trade?
Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002275.SZ in?
Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Guilin Sanjin Pharmaceutical Co., Ltd.?
Xun Zou is the chief executive officer of Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ).
Where is Guilin Sanjin Pharmaceutical Co., Ltd. headquartered?
Guilin Sanjin Pharmaceutical Co., Ltd. is headquartered in China.
Does 002275.SZ pay a dividend?
Yes — Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) paid a trailing twelve-month dividend of CNY 0.55 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002275.SZ go public?
Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) completed its initial public offering in 2009.